Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CDKN2A |
| Variant | Y44fs |
| Impact List | frameshift |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | CDKN2A Y44fs results in a change in the amino acid sequence of the Cdkn2a protein beginning at aa 44 of 156, likely resulting in a premature truncation of the functional protein (UniProt.org). Y44fs has not been characterized, however, due to the effects of other truncation mutations downstream of Y44 (PMID: 9053859, PMID: 8668202), is predicted to lead to a loss of Cdkn2a protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A Y44fs |
| Transcript | NM_000077.5 |
| gDNA | chr9:g.(21974698_21974699) |
| cDNA | c.(130_129) |
| Protein | p.Y44fs |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011517675 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_000077.5 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_001195132 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_058197 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| XM_011517676 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_000077.4 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_001195132.1 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_058197.5 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| XM_011517676.2 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_000077 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| XM_011517675.3 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| XM_011517675.2 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| XM_011517676.3 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_058197.4 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| NM_001195132.2 | chr9:g.(21974698_21974699) | c.(130_129) | p.Y44fs | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|